Pellagra: An old enemy of timeless importance

Psychosomatics

Volumn 51, Issue 2, 2010, Pages 93-97

  Brown, Thomas M ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; CLINDAMYCIN; LORAZEPAM; METRONIDAZOLE; MULTIVITAMIN; OLANZAPINE;

ADULT; ALCOHOL WITHDRAWAL; ANAMNESIS; CASE REPORT; CLINICAL FEATURE; CLOSTRIDIUM DIFFICILE INFECTION; DEPRESSION; HUMAN; MALE; PELLAGRA; REVIEW;

EID: 77949856115     PISSN: 00333182     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.psy.51.2.93     Document Type: Review

References (27)

1. Hegyi J, Schwartz RA, Hegyi V: Pellagra: dermatitis, dementia, and diarrhea. Int J Dermatol 2004; 43:1-5
2. Turner RH: The pathologic physiology of pellagra, I: Tabulated clinical and physiologic data. J Clin Invest 1931; 10:111-120
3. Prousky JE: Pellagra may be a rare secondary complication of anorexia nervosa: a systematic review of the literature. Altern Med Rev 2003; 8:180-185
4. Roberts SR: Pellagra: History, Distribution, Diagnosis, Prognosis, Treatment, Etiology. St. Louis, MO, C.V. Mosby Company, 1912
5. Spivak JL, Jackson DL: Pellagra: an analysis of 18 patients and a review of the literature. Johns Hopkins Med J 1977; 140:295-309
6. Seal AJ, Creek PI, Dibari F, et al: Low and deficient niacin status and pellagra are endemic in post-war Angola. Am J Clin Nutr 2007; 85:218-224
7. Marks HM: Epidemiologists explain pellagra: gender, race, and political economy in the work of Edgar Sydenstricker. J Hist Med Allied Sci 2003; 34-55
8. Creeke PI, Dibari F, Chejung E, et al: Whole blood NAD and NADP concentrations are not depressed in subjects with clinical pellagra. J Nutr 2007; 137:2013-2017
9. Shah GM, Shah RG, Veillette H, et al: Biochemical assessment of niacin deficiency among carcinoid cancer patients. Am J Gastroenterol 2005; 100:2307-2314
10. Beaulieu JM, Zhang X, Rodriguiz RM, et al: Role of GSK3-beta in behavioral abnormalities induced by serotonin deficiency. Proc Natl Acad Sci U S A 2008; 105:1333-1338
11. Miuller N, Schwarz MJ: The immunological basis of glutamatergic disturbance in schizophrenia: toward an integrated view. J Neural Transm Suppl 2007; 72:269-280
12. Poeggeler B, Rassoulpour A, Wu HQ, et al: Dopamine receptor activation reveals a novel, kynurenate-sensitive component of striatal N-methyl-D-aspartate neurotoxicity. Neuroscience 2007; 148:188-197
13. Ishii N, Nishihara Y: Pellagra among chronic alcoholics: clinical and pathological study of 20 necropsy cases. J Neurol Neurosurg Psychiatry 1981; 44:209-215
14. MacDonald A, Frosyth A: Nutritional deficiencies and the skin. Clin Exp Dermatol 2005; 30:388-390
15. Moore RA, Spies TD, Cooper ZK: Histopathology of the skin in pellagra. Arch Dermatol Syph 1942; 46:106-111
16. Benavente CA, Jacobson EL: Niacin restriction upregulates NADPH oxidase and ROS in human keratinocytes. Free Radic Biol Med 2008; 44:527-537
17. Hampl JS, Hampl WS: Pellagra and the origin of a myth: evidence from European literature and folklore. J Roy Soc Med 1997; 90:636-639
18. Harju E: Dietary and supplementary intake of nutrients by patients with gastrointestinal diseases. J Clin Gastroenterol 1986; 8:661-663
19. Bechgaard H, Jespersen S: GI absorption of niacin in humans. J Pharm Sci 1977; 66:871-872
20. Nabokina SM, Kashyap ML, Said HM: Mechanism and regulation of human intestinal niacin uptake. Am J Physiol Cell Physiol 2005; 289:C97-C103
21. De Ponti F: Pharmacology of serotonin: what a clinician should know. Gut 2004; 53:1520-1535
22. Abu-Qurshin R, Naschitz JE, Zuckermann E, et al: Crohn's disease associated with pellagra and increased excretion of 5-hydroxyindolacetic acid. Am J Med Sci 1997; 313:111-113
23. Forman DT: The effect of ethanol and its metabolites on carbohydrate, protein, and lipid metabolism. Ann Clin Lab Sci 1988; 18:181-189
24. Hankes LV, Leklem JE, Brown RR, et al: Tryptophan metabolism in patients with pellagra: problem of vitamin B6 enzyme activity and feedback control of tryptophan pyrrolase enzyme. Am J Clin Nutr 1971; 24:730-739
25. Laine-Cessac P, Cailleux A, Allain P: Mechanisms of the inhibition of human erythrocyte pyridoxal kinase by drugs. Biochem Pharmacol 1997; 54:863-870
26. Meyrick Thomas RH, Rowland Payne CME, et al: Isoniazid-induced pellagra. BMJ 1981; 283:287-288
27. Zaki I, Millard L: Pellagra complicating Crohn's disease. Postgrad Med J 1995; 71:496-497